SFX by Ex Libris Inc.

Title:	Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Source:	Nature [0028-0836] Barouch, D H yr:2013

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Shingai, M. "Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia." Nature 503.7475 (2013): 277-80.
description	2.	Haynes, Barton F. "AIDS/HIV. Host controls of HIV neutralizing antibodies." Science 344.6184 (2014): 588-9.
description	3.	Olinger, Gene G. "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques.(IMMUNOLOGY)(Author abstract)." Proceedings of the National Academy of Sciences of the United States of America 109.44 (2012): 18030-.
description	4.	Song, R. "Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity." Nature biotechnology 31.11 (2013): 1047-1052.
description	5.	Yamamoto, T. "Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists." Bioorganic & medicinal chemistry letters 17.13 (2007): 3736-5065.
description	6.	Kong R, R. "Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes." Journal of virology 89.5 (2014): 2659-2671.
description	7.	Schiffner, T. "Development of prophylactic vaccines against HIV-1." Retrovirology 10.1 (2013): 72-72.
description	8.	Kawai, N. "Stereoselective synthesis of (-)-diospongins A and B and their stereoisomers at C-5." Tetrahedron 63.37 (2007): 9049-9056.
description	9.	Qiu, X. "Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies." Science translational medicine 4.138 (2012): 138-138.
description	10.	Patel, P. "Estimating per-act HIV transmission risk: a systematic review." AIDS 28.10 (2014): 1509-1519.
description	11.	Richard, V. "Iron(ii)-catalysed [2+2+2] cycloaddition for pyridine ring construction." Chemical communications (London. 1996) 50.5 (2014): 593-595.
description	12.	Coutinho, Roel A. "Prospects of elimination of HIV with test-and-treat strategy." Proceedings of the National Academy of Sciences of the United States of America 110.39 (2013): 15538-15543.
description	13.	Sastraruji, K. "Synthesis of stemofoline analogues as acetylcholinesterase inhibitors." Tetrahedron 68.35 (2012): 7103-7115.
description	14.	Loram,, Lisa C., Lisa C. "Enduring Reversal of Neuropathic Pain by a Single Intrathecal Injection of Adenosine 2A Receptor Agonists: A Novel Therapy for Neuropathic Pain." The journal of neuroscience 29.44 (2009): 14015-14025.
description	15.	Qiu, X. "Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb." Scientific Reports 3.1 (2013): 3365-3365.
description	16.	Joyce, Joseph G. "Pushing the envelope on HIV-1 neutralization: the identification of broadly neutralizing monoclonal antibodies against HIV-1 may aid efforts to design a vaccine." Nature biotechnology 28.9 (2010): 929-.
description	17.	Leavy, O. "Natural killer cells: A virtual pick and mix." Nature reviews. Immunology (2013).
description	18.	Havelda, Z. "Plant virus infection-induced persistent host gene downregulation in systemically infected leaves." The plant journal 55.2 (2008): 278-288.
description	19.	Lynch, G W W. "Analysis of recombinant and native CD4 by one- and two-dimensional gel electrophoresis." Electrophoresis 34.8 (1995): 227-34.
description	20.	Pulito, V L L. "Humanization and molecular modeling of the anti-CD4 monoclonal antibody, OKT4A." The journal of immunology 156.8 (1996): 2840-50.